Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Blood test accurately detects over 50 types of cancer, often before symptoms show
Researchers have developed the first blood test that can accurately detect more than 50 types…
New Victorian COVID-19 Cancer Network
Victorian Comprehensive Cancer Centre alliance and Monash Partners Comprehensive Cancer Consortium Join Forces to Coordinate…
Crumpled graphene makes ultra-sensitive cancer DNA detector
Graphene-based biosensors could usher in an era of liquid biopsy, detecting DNA cancer markers circulating…
Acceptance and commitment therapy may ease fear of recurrence in cancer survivors
- Youngest Australian breast cancer patient urges women to be ‘breast aware’ this October
- ESMO 2019: Two studies show CDK4/6 inhibitors improve overall survival in advanced breast cancer
- ESMO 2019: New data from the TAILORx study on cohort with recurrence score 26-100 shows 93% cancer-free rate at 5 years
More than one-third of cancers can be avoided if Australians modify their lifestyle
Sasha Petrova, The Conversation Nearly 40,000 cancers diagnosed in Australia can be prevented if people avoid known risk factors for…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.